Lawmakers are set to scrutinize the high cost of weight loss and diabetes drugs, which depending upon your insurance can ...

Novo Nordisk's CEO is set to face U.S. congressional scrutiny over the high prices of its diabetes and weight loss drugs, ...

Good evening! The last full-size Kmart store in the United States is closing. On a brighter note, the Philadelphia Phillies ...

The CEO of Novo Nordisk will testify in the Senate HELP Committee tomorrow about the cost of popular diabetes and weight loss ...

As the Senate Committee on Health, Education, Labor and Pensions (HELP) gears up for a hearing tomorrow titled “Why Is Novo ...

Hearing on weight loss drug prices will feature CEO of Novo Nordisk and comes after threats to subpoena company executives.

Ahead of a Senate hearing centered on high prices for Novo Nordisk’s in-demand semaglutide medications, lawmakers are ...

Novo Nordisk's blockbuster diabetes drug Ozempic will be eligible for U.S. government's price negotiations in less than a ...

Novo Nordisk braced for a congressional inquiry into the high prices of weight loss and diabetes drugs, particularly Ozempic, ...

As a possible indication that the hearing, which starts at 10a ET, could get contentious, it has the title, "Why is Novo ...

Novo Nordisk CEO Lars Jergensen testified on the company's pricing for its diabetes and weight loss drugs, Ozempic and Wegovy, respectively. Public affairs events, congressional hearings, speeches, ...

Ozempic and Wegovy are making so much money for Novo Nordisk A/S that their cumulative sales will soon surpass the ...